 SARASOTA, Fla. and SAN FRANCISCO, April 19, 2021 PRNewswire -- INVO Bioscience, Inc. NASDAQ: INVO, a medical device company focused on commercializing the worlds only in vivo Intravaginal Culture System IVC, INVOcell, an effective and affordable treatment for patients diagnosed with infertility, today announced the execution of a partnership agreement with Lyfe Medical, LLC Lyfe Medical focused on the expansion of the INVOcell solution in Northern California with an area population of 8 million people. 